Brent James, M.D., an expert on clinical quality improvement and patient safety, told Fierce Healthcare in an email that medicine has a long history of overreacting to a new drug and then quietly moving on when the full set of circumstances become known
Obesity is a chronic metabolic disease that needs lifelong treatment. Dr
Recommended protocol: Washout: 20 to 25 days Starting dose: 1mg weekly Week 5: escalate to 2mg Week 9: escalate to 4mg Week 13: escalate to 8mg Week 17: consider 12mg based on response and tolerance This protocol follows the standard retatrutide peptide dosage chart exactly, treating you similarly to a GLP-1 naive individual
Just as importantly, most either have no side effects or find them entirely manageable
Practical supports are the ones that let you detect change early: Frequent weight checks Simple glucose logs if relevant Short follow-up visits in the first few weeks Clinicians may discuss alternative options such as different GLP-1 agents or combination therapies if weight or glucose control slips
Until then, the Phase 2 data are unambiguous: adding the glucagon receptor to the GLP-1/GIP framework appears to yield greater fat loss meaningfully, at the cost of a somewhat higher side-effect burden
